Fresenius Medical Care AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US3580291066

SecurityFMS / Fresenius Medical Care AG - Depositary Receipt (Common Stock)
InstitutionSkopos Labs, Inc.
Latest Disclosed Ownership14,793 shares
Latest Disclosed Value $ 333,729
Skopos Labs, Inc. reports 66.96% increase in ownership of FMS / Fresenius Medical Care AG - Depositary Receipt (Common Stock)

On April 29, 2026 - Skopos Labs, Inc. filed a 13F-HR form disclosing ownership of 14,793 shares of Fresenius Medical Care AG - Depositary Receipt (Common Stock) (US:FMS) valued at $333,730 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 8,860 shares of Fresenius Medical Care AG - Depositary Receipt (Common Stock). This represents a change in shares of 66.96% during the quarter. The current value of the position is $309,174 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F FRESENIUS MED CARE AG&CO KGA SPONSORED ADR 358029106 14,793 5,933 66.96 334 57.82 0.0104
2026-02-12 2025-12-31 13F FRESENIUS MED CARE AG&CO KGA SPONSORED ADR 358029106 8,860 450 5.35 212 -4.52 0.0098
2025-11-14 2025-09-30 13F FRESENIUS MED CARE AG&CO KGA SPONSORED ADR 358029106 8,410 4,338 106.53 221 90.52 0.0153
2025-08-14 2025-06-30 13F/A-1 FRESENIUS MED CARE AG&CO KGA SPONSORED ADR 358029106 4,072 2,787 216.89 116 274.19 0.0153
2025-08-12 2025-06-30 13F FRESENIUS MED CARE AG&CO KGA SPONSORED ADR 358029106 1,285 0 32 0.0069
2025-05-13 2025-03-31 13F FRESENIUS MED CARE AG&CO KGA SPONSORED ADR 358029106 1,285 1,040 424.49 32 520.00 0.0069
2025-01-15 2024-12-31 13F FRESENIUS MED CARE AG&CO KGA SPONSORED ADR 358029106 245 245 6 0.0017
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.